• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1994 Fiscal Year Final Research Report Summary

Development of new quality control method for oral live vaccine using transgenic mice susceptible to poliovirus.

Research Project

Project/Area Number 04507002
Research Category

Grant-in-Aid for Developmental Scientific Research (A)

Allocation TypeSingle-year Grants
Research Field Virology
Research InstitutionNational Institute of Health

Principal Investigator

KURATA Takeshi  NIH,Dept.of Pathology, Director, 感染病理部, 部長 (50012779)

Co-Investigator(Kenkyū-buntansha) DOI Yutaka  Japan Poliomyelitis Research Institute, Laboratory Div., Director, 部長 (00110354)
CHINO Fumitoshi  NIH,Dept.of Safety Reseach on Biologics, Director, 安全性研究部, 部長 (80072908)
ARITA Mineo  NIH,Dept of Viral Disease and vaccine Control, Director, ウイルス製剤部, 部長 (90100065)
AOKI Junken  Metropolitan Institute for Medical Science, Dept.of Microbiology, Researcher, 微生物部, 研究員 (20250219)
NOMURA Tatsuji  Central Institute for Experimental Animals, Director General, 所長 (10072399)
Project Period (FY) 1992 – 1994
KeywordsPoliovirus / PVR / Transgenic mice
Research Abstract

Transgenic mice (Tg mice) carrying the human poliovirus receptor gene were susceptible to poliovirus infection showing paralysis of extremities. The pathological findings of paralytic mice were quite similar to the neuropathological changes in humans died of poliomyelitis. In this study, neuropathological changes in Tg mice inoculated with virulent strain, vaccine and field-isolates were compared to the conventional neurovirulence test using monkeys whether Tg mice are useful instead of monkeys for neurovirulence test of poliovirus vaccine.
(1) Neurovirulence was observed parallel to the virus titer.
(2) Intra-spinal cord administration route was established.
(3) Intracerebral in oculation of field-isolates resulted in clear histopathological changes (inflammatory cell infiltration, degeneration of neurones, especially atrophy) with viral antigen in paralytic Tg mice. But in Tg mice without clinical signs no pathological changes were revealed.
(4) Lesion score in monkeys was compared in Tg 21 mice by PD50 method using poliovirus type 1 and 3, and high correlation was observed reproductively and this measurement system is more precise than conventional monkey system.
(5) In neurovirulence test of Tg 21 mice, high correlation was seen between in vitro poliovirus marker test and rct marker in monkeys.
(6) The above results in Tg 21 mice reflects more objectively than in test using monkeys from the points of neurovirulence.
(7) Stable supplying system of Tg mice was established.

  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] Horie H.,Koike S.,Kurata T.,et al: "Transgenic mice carrying human poliovirus recptor : New Animal model for study of poliovirus neurovirulence" J.Virology. 68. 681-688 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Aoki J.,Koike S.,Ise I. et al.: "Amino acid residues on human poliovirus receptor involved in interaction with poliovirus" J Biological Chemistry. 269. 8431-3438 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Abe S.,Ota Y.,Koike S,Kurata T.,et al: "Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice" Virology. 206. 1075-1083 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koike S.,Taya C.,Aoki J.,et al: "Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene-- influence of the cransgene expression on pathogenesis" Arch Virol. 139. 351-363 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nomoto A.,Koike J.,and Aoki J.: "Tissue tropism and species specificity of poliovirus infection" Trends in Microbiology. 2. 47-51 (1994)

    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 1996-04-15  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi